Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV. [electronic resource] by
- Payer, B A
- Reiberger, T
- Breitenecker, F
- Aichelburg, M C
- Schuster, C
- Heil, P M
- Scherzer, T M
- Ferenci, P
- Rieger, A
- Peck-Radosavljevic, M
Producer: 20121024
In:
The Journal of infection vol. 65
Availability: No items available.
|
|
10.
|
Viral determinants predicting hepatitis B surface antigen (HBsAg) seroclearance in HIV-/HBV-coinfected patients. [electronic resource] by
- Strassl, R
- Reiberger, T
- Honsig, C
- Payer, B A
- Mandorfer, M
- Grabmeier-Pfistershammer, K
- Rieger, A
- Kundi, M
- Grundtner, P
- Peck-Radosavljevic, M
- Popow-Kraupp, T
Producer: 20150126
In:
Journal of viral hepatitis vol. 21
Availability: No items available.
|
|
11.
|
Revisiting predictors of virologic response to PEGIFN + RBV therapy in HIV-/HCV-coinfected patients: the role of metabolic factors and elevated GGT levels. [electronic resource] by
- Mandorfer, M
- Reiberger, T
- Payer, B A
- Breitenecker, F
- Aichelburg, M C
- Obermayer-Pietsch, B
- Rieger, A
- Puoti, M
- Zangerle, R
- Trauner, M
- Peck-Radosavljevic, M
Producer: 20140730
In:
Journal of viral hepatitis vol. 21
Availability: No items available.
|